SHERPA aims to significantly ease the workload of interventional radiologists, boost clinical accuracy, and improve patient outcomes by providing advanced assistive technologies powered by artificial intelligence (AI).

The project will carry out 7 clinical studies focussing on 2 use cases: Brain Aneurysms and Liver Tumours. While the former focusses on AI-driven detection, risk prediction, and precise treatment planning, the second use case is dedicated to robotic-assisted thermal ablation.

HFC is part of the SHERPA core team for research methodology and contributes its expertise in the fields of human factors, psychology, usability and human-machine interaction to the preparation, alignment and implementation of the user research.

You can find our project on LinkedIn: linkedin.com/showcase/sherpa-ihi

Funded by the European Union (101194744). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or Innovative Health Initiative Joint Undertaking. Neither the European Union nor the granting authority can be held responsible for them.

The project is supported by the Innovative Health Initiative and its members